SAR-bisPSMA: Latest Updates on Next Generation Theranostics in Prostate Cancer
Time: 11:30 am
day: Day Two LSC AM
Details:
- Demonstrating robust therapeutic safety profile
- Revealing enhanced imaging
- Explore future perspectives for SAR-bisPSMA
